| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/14/2004 | EP1435944A1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 07/14/2004 | EP1435785A1 Iminobenzoxazines, iminobenzothiazines and iminoquinazolines for controlling invertebrate pests |
| 07/14/2004 | EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/14/2004 | EP1235803B1 Urea compounds having muscarinic receptor antagonist activity |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1204323B1 Fungicides |
| 07/14/2004 | EP1077940B1 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 07/14/2004 | CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer |
| 07/14/2004 | CN1512991A 吡咯烷双环化合物 Pyrrolidine bicyclic compound |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1511837A Intermediate for heterocyclic compound in preparing rotamase inhibitor |
| 07/14/2004 | CN1511833A Process for preparing isoxazolyl alkyl diketone compound |
| 07/14/2004 | CN1511832A Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1157391C Method and intermediate for preparing is-a-oxazole formylamine and its analogue |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762198 Such as 2-((4'-methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl)-amino-3-(2-phenoxymethyl -(1,3)dioxan-2-yl)propionic acid |
| 07/13/2004 | US6762197 Fungicides |
| 07/13/2004 | US6762194 Quinolinone derivatives |
| 07/13/2004 | US6762152 Four to seven membered heterocycles substituted on benzene ring; reaction of a ketone with a substituted benzoic acid |
| 07/08/2004 | WO2004056998A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | WO2004056819A1 Oxazolidinone derivatives as antibacterial agents |
| 07/08/2004 | WO2004056818A1 Oxazolidinone derivatives as antibacterial |
| 07/08/2004 | WO2004056817A1 Oxazolidinone derivatives and their use as antibacterial agents |
| 07/08/2004 | WO2004056816A1 Antibacterial oxazolidinones |
| 07/08/2004 | WO2004056815A1 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 07/08/2004 | WO2004056814A1 Oxazoles as mglur1 enhancer |
| 07/08/2004 | WO2004056812A1 4- (pyridin-4-ylamino) -quinazoline derivatives as anti-tumor agents |
| 07/08/2004 | WO2004056807A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 07/08/2004 | WO2004056805A1 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056799A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056789A1 Mek inhibiting oxa- and thia-diazol-2-yl phenylamine derivates |
| 07/08/2004 | WO2004056788A1 Benzoxazocines and their use as monoamine-reuptake inhibitors |
| 07/08/2004 | WO2004056786A2 Pyrimidine derivates for the treatment of abnormal cell growth |
| 07/08/2004 | WO2004056785A2 Uracils having a herbicidal activity |
| 07/08/2004 | WO2004056784A1 Novel carboxamides, the production and use thereof as medicaments |
| 07/08/2004 | WO2004056782A1 Pyrazole compounds |
| 07/08/2004 | WO2004056780A2 Tetrahydroquinoline derivatives |
| 07/08/2004 | WO2004056775A1 Microsomal triglyceride transfer protein inhibitors |
| 07/08/2004 | WO2004056774A2 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
| 07/08/2004 | WO2004056772A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists |
| 07/08/2004 | WO2004056766A1 Inhibitors of tace |
| 07/08/2004 | WO2004056727A2 Process of making chalcone derivatives |
| 07/08/2004 | WO2004056369A1 Benzo ‘ d!azepine derivatives for the treatment of neurological disorders |
| 07/08/2004 | WO2004056365A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 07/08/2004 | WO2004056364A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056347A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer |
| 07/08/2004 | WO2004041210A3 Antibacterial agents |
| 07/08/2004 | WO2004032882A3 Chemical compounds |
| 07/08/2004 | WO2004022060A3 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| 07/08/2004 | WO2004014902A3 Compounds having an activity at metabotropic glutamate receptors |
| 07/08/2004 | WO2003106628A3 Benzodiazepine inhibitors of mitochondial f¿1<f¿0? atp hydrolase and methods of inhibiting f¿1?f¿0? atp hydrolase |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003103599A3 Caspase-1 inhibitors and methods for their use |
| 07/08/2004 | WO2003097593A3 Protease inhibitors |
| 07/08/2004 | US20040133011 Useful for therapy of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome |
| 07/08/2004 | US20040132792 Oxazoles as mGluR 1 enhancers |
| 07/08/2004 | US20040132791 N-(on SO2 ) (2-hydroxy-3-substituted aminopropyl)-substituted; inhibiting retroviral replication |
| 07/08/2004 | US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain. |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132779 benzoyl- or pyridinoyl-amimo phenyl- or pyridinylmethylaminocarbonyl compounds, e.g., 4-[(2-acetylamino-2-phenyl-acetylamino)-methyl]-2-methylphenyl-4'-trifluoromethylbiphenyl-2-carboxamide; antiobesity and antiatherosclerosis agents |
| 07/08/2004 | US20040132772 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 07/08/2004 | US20040132755 Isoxazoles and uses thereof |
| 07/08/2004 | US20040132741 N-sulfonylindoles and N-sulfonylindazoles; treating motor disorders, anxiety disorders or cognitive disorders, such as schizophrenia, depression, Alzheimer's disease or Parkinson's disease |
| 07/08/2004 | US20040132732 Quinazolinones and derivatives thereof as factor Xa inhibitors |
| 07/08/2004 | US20040132730 Inhibitors of TGFbeta |
| 07/08/2004 | US20040132726 New compounds |
| 07/08/2004 | US20040132721 Treatment of airway disorders |
| 07/08/2004 | US20040132720 Antidepressants |
| 07/08/2004 | US20040132718 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| 07/08/2004 | US20040132710 Lactams as tachkinin antagonists |
| 07/08/2004 | US20040132673 Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same |
| 07/08/2004 | US20040132619 Activity; crop compatibility; broad spectrum; cereals |
| 07/08/2004 | US20040132115 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity |
| 07/08/2004 | US20040131885 Organic electroluminescent device and organic electroluminescent compound thereof |
| 07/08/2004 | DE10261874A1 Nichtsteroidale Entzündungshemmer Nonsteroidal anti-inflammatory drugs |
| 07/08/2004 | DE10257358A1 Substituierte Pyrrole Substituted pyrroles |
| 07/08/2004 | DE10237723A1 Verwendung von IKappaB-Kinase Inhibitoren in der Schmerztherapie Use of IkappaB kinase inhibitors in the treatment of pain |
| 07/08/2004 | CA2511321A1 Pyrazole-derivatives as factor xa inhibitors |
| 07/08/2004 | CA2510848A1 Pyrimidine derivates for the treatment of abnormal cell growth |
| 07/08/2004 | CA2510846A1 New carboxylic acid amides,the preparation thereof and their use as pharmaceutical compositions |
| 07/08/2004 | CA2510815A1 Microsomal triglyceride transfer protein inhibitors |
| 07/08/2004 | CA2510471A1 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
| 07/08/2004 | CA2510069A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | CA2509405A1 Mek inhibiting oxa- and thia-diazol-2-yl phenylamine derivatives |
| 07/08/2004 | CA2509403A1 Pyrazole compounds |
| 07/08/2004 | CA2508657A1 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | CA2506826A1 Uracils having a herbicidal activity |
| 07/08/2004 | CA2503172A1 Benzoxazocines and their use as monoamine-reuptake inhibitors |
| 07/07/2004 | EP1435356A1 Quinoline derivatives as CRTH2 antagonists |
| 07/07/2004 | EP1435353A1 Novel heterocyclic compound and anti-inflammatory agent |
| 07/07/2004 | EP1434774A1 3-(4-substituted heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 07/07/2004 | EP1434773A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 07/07/2004 | EP1434765A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 07/07/2004 | EP1434763A2 Beta-lactamyl vasopressin v1a antagonists |
| 07/07/2004 | EP1434583A1 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/07/2004 | EP1434577A1 Pyrrolidinone derivatives |
| 07/07/2004 | EP0946552B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/07/2004 | CN1511192A Production of polyketides |
| 07/07/2004 | CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives |